King Wealth Management Group’s DexCom DXCM Stock Holding History

King Wealth Management Group’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-4,000	Closed	-$269K	–	167
2025 Q3	$269K	Buy	+4,000	New	+$317K	0.03%	136

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JSC

J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

King Wealth Management Group's DXCM Position: Q4 2025 in Review

King Wealth Management Group sold out of DexCom (DXCM) in Q4 2025, closing a stake of 4,000 shares — an estimated $269K sold.

King Wealth Management Group first reported a position in DXCM in Q3 2025 and held it in 1 quarter. The position peaked at $269K in Q3 2025. 922 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

King Wealth Management Group reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
King Wealth Management Group sold 4,000 DexCom shares in Q4 2025, an estimated $269K.
King Wealth Management Group first reported a position in DexCom in Q3 2025 and held it in 1 quarter.
King Wealth Management Group's DexCom position peaked at $269K in Q3 2025.
922 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on King Wealth Management Group's 13F filing for Q4 2025, filed 9 Feb 2026.